Global Cancer Biological Therapy Market 2018 Size, Development Status, Type and Application, Segmentation, Forecast by 2023

WiseGuyReports.com adds “Cancer Biological Therapy Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023”reports to its database.

Pune, India - January 12, 2018 /MarketersMedia/ —

Cancer Biological Therapy Market:

Executive Summary

Biological therapy treatment is done with the help of living organisms, parts of living organisms or laboratory manufactured version of such content. There are various types of biological therapies, which inhibit specific molecules involved in development and growth of cancer tumor. Such therapies known as; cancer targeted therapies.

The global cancer biological therapy market is expected to reach USD 82,276.8 million by 2023 at a CAGR of 4.7% during the forecasted period.  

The global cancer biological therapy market is segmented on the basis of phases, types, end users and regions. On the basis of phases, the market is segmented into phase I, phase II and phase III. In stage I & II the real impact of these therapies is seen and giving a success rate of 35% in Phase 1 and 20% in Phase II. The success rate of phase I is 35%.

On the basis on types, the global cancer biological therapy market is segmented into monoclonal antibodies, cancer growth blockers, interferons, interleukins, gene therapy, targeted drug delivery, colony stimulating factor, cancer vaccines and others. Monoclonal antibodies accounted for the largest market share of the global cancer biological therapy market. Colony stimulating factor is the fastest growing market at a CAGR of 5.2% during the forecasted period.

On the basis on end users, hospitals & clinics dominates the global cancer biological therapy market. Registering USD 26,790.6 million in 2016 and expected to reach at USD 38,471.9 million by 2023 at the rate of 4.4 % from 2016-2023. 

On the basis of regions, the market is segmented into North America, Europe, Asia-Pacific and the Middle East & Africa. North America has the dominating market for cancer biological therapy. The cancer biological therapy market for North America is estimated at USD 19,481.2 million in 2016 and expected to reach by USD 29,516.9 million by 2023 at a fastest CAGR of 5.10%.

Request Sample Report @ https://www.wiseguyreports.com/sample-request/1793685-global-cancer-biological-therapy-analysis-forecast-2016-to-2023

Key Players

The leading market players in the global cancer biological therapy market include Merck Inc., F. Hoffmann-La Roche Ltd, Novartis AG, Amgen Inc., Bristol-Myers Squibb, Celgene, ELI Lilly and Company, EnGeneIC, and Pfizer

Study objectives

To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global cancer biological therapy market
To provide insights about factors influencing and affecting the market growth
To provide historical and forecast revenue of the market segments and sub-segments with respect to countries
To provide historical and forecast revenue of the market segments based on channels, applications, and regions for the global cancer biological therapy market.
To provide strategic profiling of key players in the market, and comprehensively analysing their market share, core competencies, and drawing a competitive landscape for the market
To provide economical factors that influences the global cancer biological therapy market
To provide detailed analysis of the value chain and supply chain of the global cancer biological therapy market

Target Audience

Pharmaceutical Companies
Pharmaceutical Suppliers
Cancer Research Organizations
Potential Investors
Key Executive (CEO and COO) and Strategy Growth Manager
Reaserch Companies

For further information on this report, visit - https://www.wiseguyreports.com/enquiry/1793685-global-cancer-biological-therapy-analysis-forecast-2016-to-2023

Key Findings

North America accounted for the largest market share in the global cancer biological therapy market, USD 19,481.2 million in 2016 and expected to reach by USD 29,516.9 million by 2023 at a fastest CAGR of 5.10%
Colony stimulating factor is the fastest growing segment with a CAGR of and 5.2% in the global cancer biological therapy market, by types
Hospitals and clinics is contributing remarkable share in the market registering 47.8% in the global cancer biological therapy market, by end users in 2016

The reports also covers regional analysis

North America
o US

o Canada

Europe
o Germany

o France

o U.K.

o Italy

o Spain

o Rest of Europe

Asia Pacific
o Japan

o China

o India

o Republic of Korea

o Rest of Asia-Pacific

Middle East & Africa
o Middle East

o Africa

Continuous…

Buy this Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1793685

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: Wise Guy Research Consultants Pvt Ltd
Address: Office No. 528, Amanora Chambers Pune - 411028 Maharashtra, India
Phone: +1-646-845-9349 (US); +44 208 133 9349 (UK)

Source URL: https://marketersmedia.com/global-cancer-biological-therapy-market-2018-size-development-status-type-and-application-segmentation-forecast-by-2023/286775

For more information, please visit https://www.wiseguyreports.com/reports/1793685-global-cancer-biological-therapy-analysis-forecast-2016-to-2023

Source: MarketersMedia

Release ID: 286775

Latest News

Former Malaysian leader Najib grilled by anti-graft agency

May 22, 2018

PUTRAJAYA, Malaysia — Former Malaysian Prime Minister Najib Razak was grilled for more than four hours Tuesday over a corruption scandal that could lead to criminal charges against him, while the country's new anti-graft chief said investigations into the case were suppressed by intimidation during Najib's rule. Najib was summoned by Malaysia's Anti-Corruption Commission nearly two weeks after the defeat of his long-ruling coalition in national elections amid public anger over alleged graft at the 1MDB state investment fund that Najib set up. U.S. investigators say Najib's associates stole and laundered $4.5 billion from the fund from 2009 to 2014,...

Stars urge Indonesia to ban 'brutal' trade in dog meat

May 22, 2018

JAKARTA, Indonesia — International stars of acting, music and sports have urged Indonesia's president to ban what they say is a brutal trade in dog and cat meat for human consumption. The appeal comes after Indonesian campaigners against animal cruelty and Humane Society International in January exposed markets on the island of Sulawesi where dogs were bludgeoned by the thousands and blow-torched alive to remove their hair before onlookers including children. The letter to President Joko "Jokowi" Widodo released Monday said if Indonesia joined other Asian nations that have already banned the cruel trade, it would be "celebrated globally" and...

Malaysians transfixed by luxury goods seized from ex-PM flat

May 22, 2018

KUALA LUMPUR, Malaysia — In 10 days of dramatic political developments, none has transfixed Malaysians more than the sight of truckloads of orange boxes containing Hermes Birkin handbags and luggage filled with cash and jewelry being seized from apartments linked to former Prime Minister Najib Razak. Najib's wife, Rosmah Mansor, was known for her love of Birkin bags and her opulent lifestyle, but television footage of the police haul has Malaysia gasping with shock. It is possibly the most sensational image of elite corruption in Asia in the three decades since former Philippine first lady Imelda Marcos and her extravagant...

Malaysia anti-graft body summons ex-PM Najib for questioning

May 22, 2018

KUALA LUMPUR, Malaysia — A Malaysian official says former Prime Minister Najib Razak has been summoned for questioning in a money-laundering probe involving the 1MDB state investment fund. The official at Malaysia's Anti-Corruption Commission, who declined to be identified because of the case's sensitivity, says the commission served a notice to Najib at his house Friday requesting that he appear next Tuesday for questioning in the 1MDB case. The official said Najib acknowledged the request. Najib's lawyer, Harpal Singh Grewal, said he wasn't aware of the summons but that Najib had earlier promised to cooperate with authorities. The new government...

AP Interview: Anwar wants Malaysia to scrap race policies

May 22, 2018

KUALA LUMPUR, Malaysia — Pardoned Malaysian politician Anwar Ibrahim said Thursday that decades-old affirmative action policies for the country's Malay majority must be discarded in favor of a new program to help the poor regardless of race. In an interview with The Associated Press, the prime minister-in-waiting also said he plans to run in a by-election this year to become a member of Parliament but that he isn't in a rush to take over the top job. Anwar, 70, was convicted of sodomy in 2015 in a case he said was politically motivated. His sentence expires June 8 but he...

Penggerak pasaran mengikut TradingView

About Us

Duniaga is Malaysia’s top local source for business news and information where people head to stay connected with the business news. We give daily in-depth analysis on the business happenings in the country.

Contact us: sales[at]duniaga.com

Subscribe Now!